Puig Alcántara, Josep (Date of defense: 2014-12-03)
Introducción: El infarto cerebral és una de las primeras causas de morbi-mortalidad en nuestra sociedad. La fibrinolisis intravenosa con activador tisular del plasminógeno es el tratamiento de elección ...
Sanjuan Menéndez, Estel·la (Date of defense: 2014-12-12)
Objetivo:Determinar si los criterios clásicos de activación del Código Ictus (CCACI) permiten seleccionar de manera adecuada aquellos pacientes candidatos a recibir tratamientos de reperfusión ...
Robles Cedeño, René (Date of defense: 2016-07-19)
Multiple sclerosis is a chronic disease of the central nervous system which has an unknown aetiology and an autoimmune mechanism. Two pathogenic processes, inflammation and neurodegeneration, converge ...
Gubern Mérida, M. Carme (Date of defense: 2015-12-18)
Cerebral ischaemia is a potent inducer of gene expression, however, little is known about the mechanisms that regulate this expression. Studies of gene expression and the study of the mechanisms regulating ...
Comajoan von Arend, Pau (Date of defense: 2019-12-18)
Recombinant tissue plasminogen activator (rt-PA) is currently the only FDA-approved drug for the treatment of acute ischaemic stroke. However, the application of this therapy is limited to <5-7% of ...
616.1 - Pathology of the circulatory system, blood vessels. Cardiovascular complaints (3)
616.8 - Neurology. Neuropathology. Nervous system (3)
575 - General genetics. General cytogenetics (2)
57 - Biological sciences in general (1)
577 - Material bases of life. Biochemistry. Molecular biology. Biophysics (1)